Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Hanjing Emily Wu

University of Texas Health, USA

Title: Serum BDNF, TNFα, IL -2, IL- 6, IL – 8 changes and correlation in schizophrenia patients

Biography

Biography: Hanjing Emily Wu

Abstract

Numerous studies report that abnormalities in both Brain-Derived Neurotrophic Factor (BDNF) and cytokines may be involved in the pathophysiology of schizophrenia. While recent studies have shown that immunocytokines interact with BDNF, however, the possible interaction between BDNF and cytokines; and their role in the psychopathology of schizophrenia have not been reported. We have analyzed serum BDNF, tumor necrosis factor-alpha (TNFα), Interleukin (IL)-2, IL-6 and IL-8 levels from the blood samples of 92 chronically medicated schizophrenia patients and 60 healthy controls. Th e symptoms of schizophrenia were assessed using the Positive and Negative Syndrome Scale (PANSS) with cognitive and depressive factors derived from the fi ve-factor model of the PANSS. Compared to the control group, the schizophrenia patients’ samples have signifi cantly decreased levels of BDNF and TNFα, but signifi cantly increased level of IL-2, IL-6 and IL-8. In patients, but not in controls, we observed a significant negative correlation between BDNF and IL-2; and between BDNF and IL-8. Furthermore, the negative correlation between BDNF and IL-8 was associated with the PANSS depressive factor, while decreased levels of BDNF and TNFα were associated with the PANSS cognitive factor. The decreased level of BDNF and change of immunocytokines level may be implicated in the pathophysiology of chronic schizophrenia. Moreover,immunocytokines may interact withBNDF in schizophrenia, which may contribute to the clinical symptoms and cognitive impairment of schizophrenia.

Speaker Presentations